Pharma

In a striking move toward collaborative innovation, Bristol Myers Squibb, Takeda, AbbVie, and Johnson & Johnson have joined forces through a shared data consortium to advance AI-enabled drug discovery. Their objective is to pool proprietary protein-small molecule datasets via a federated learning framework, enabling secure contributions without exposing sensitive information. This collective approach aims to…